Data on hyper-activation of GPVI signalling in obese patients: Towards the identification of novel antiplatelet targets in obesity
Year: 2019
Type: data-paper
Abstract: This data article is associated with the manuscript "GPVI surface expression and signalling pathway activation are increased in platelets from obese patients: elucidating potential anti-atherothrombotic targets in obesity" [1]. The study refers to a combination of different approaches in order to identify platelet-derived biomarkers in obesity. A total of 34 obese patients and their lean-matched controls were included in the study. We carried out a proteomic and functional (aggregation assays) analysis to find alterations in platelet-derived signalling pathways. After that, biochemical and mechanistic (flow cytometry assays) approaches were done in order to confirm a hyperactivation of the GPVI-related signalling pathway.
Source: Data in Brief
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $553
Awards: G1450903212, GPVI-dimer, a specific target in ischaemic heart disease and stroke, G3876637791, Collagen-like peptides: synthetic tools to investigate vascular cell function in health and disease (renewal). ,, G4948256279, G5720423750, G8612360239, Defining the GPVI-dimer-fibrin interaction in collagen-independent thrombus formation. ,
OpenAlex ID: W2919723341
